Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $25.11 in the prior trading day, Apellis Pharmaceuticals Inc (NASDAQ: APLS) closed at $24.41, down -2.79%. In other words, the price has decreased by -$2.79 from its previous closing price. On the day, 1.65 million shares were traded. APLS stock price reached its highest trading level at $25.03 during the session, while it also had its lowest trading level at $24.12.
Ratios:
Our goal is to gain a better understanding of APLS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.81 and its Current Ratio is at 4.25. In the meantime, Its Debt-to-Equity ratio is 2.06 whereas as Long-Term Debt/Eq ratio is at 2.03.
On November 21, 2024, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $31.
On October 25, 2024, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $25.RBC Capital Mkts initiated its Sector Perform rating on October 25, 2024, with a $25 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 17 ’25 when Chopas James George sold 183 shares for $24.82 per share. The transaction valued at 4,543 led to the insider holds 47,955 shares of the business.
Chopas James George bought 183 shares of APLS for $4,543 on Mar 17 ’25. On Mar 05 ’25, another insider, Watson David O., who serves as the General Counsel of the company, sold 5,569 shares for $25.10 each. As a result, the insider received 139,789 and left with 138,730 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLS now has a Market Capitalization of 3063845632 and an Enterprise Value of 3117487872. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.92 while its Price-to-Book (P/B) ratio in mrq is 13.30. Its current Enterprise Value per Revenue stands at 3.99 whereas that against EBITDA is -19.104.
Stock Price History:
The Beta on a monthly basis for APLS is 0.78, which has changed by -0.5603386 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, APLS has reached a high of $59.91, while it has fallen to a 52-week low of $23.77. The 50-Day Moving Average of the stock is -13.38%, while the 200-Day Moving Average is calculated to be -25.90%.
Shares Statistics:
The stock has traded on average 1.73M shares per day over the past 3-months and 1350500 shares per day over the last 10 days, according to various share statistics. A total of 124.50M shares are outstanding, with a floating share count of 104.48M. Insiders hold about 16.76% of the company’s shares, while institutions hold 99.44% stake in the company. Shares short for APLS as of 1740700800 were 20815049 with a Short Ratio of 12.05, compared to 1738281600 on 17055810. Therefore, it implies a Short% of Shares Outstanding of 20815049 and a Short% of Float of 22.639999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
